ArticleDiabetologia2023

SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study.

Matthew Anson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.